Thalia F. Van Der Doef
Utrecht, UT, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Does insulin resistance influence neurodegeneration in non-diabetic Alzheimer's subjects?
Journal: Alzheimer's research & therapy
Published: November 14, 2020
First-in-man study to investigate safety, pharmacokinetics and exploratory pharmacodynamics of HTL0018318, a novel M1 -receptor partial agonist for the treatment of dementias.
Journal: British journal of clinical pharmacology
Published: September 16, 2020
Microglial activation in schizophrenia: Is translocator 18 kDa protein (TSPO) the right marker?
Journal: Schizophrenia research
Published: May 30, 2019
New approaches in psychiatric drug development.
Journal: European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology
Published: March 17, 2018
Human Dosimetry of the N-Methyl-d-Aspartate Receptor Ligand 11C-GMOM.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: December 06, 2016
In vivo (R)-[(11)C]PK11195 PET imaging of 18kDa translocator protein in recent onset psychosis.
Journal: NPJ schizophrenia
Published: December 15, 2015
Quantification of the novel N-methyl-d-aspartate receptor ligand [11C]GMOM in man.
Journal: Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism
Published: February 24, 2015
Assessing brain immune activation in psychiatric disorders: clinical and preclinical PET imaging studies of the 18-kDa translocator protein.
Journal: Clinical and translational imaging
Published: January 01, 2015
Dopaminergic activity in Tourette syndrome and obsessive-compulsive disorder.
Journal: European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology
Published: January 24, 2013
Showing 1-9 of 9
Last Updated: 09/26/2026